Researchers have linked a popular HIV Aids drug currently in use among Kenyan patients to kidney damage.
Tenofovir, commonly referred to as TR, is one of the most widely used antiretroviral (ARV) medication in Kenya. It is also a component of Truvada, a recently introduced daily pill for HIV prevention in Kenya.